Trial Profile
Non-inferiority Trial Comparing Insulin Glulisine to Insulin Lispro as Part of a Basal-bolus Insulin Regimen for the Treatment of Gestational Diabetes.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2020
Price :
$35
*
At a glance
- Drugs Insulin glulisine (Primary) ; Insulin; Insulin lispro
- Indications Gestational diabetes; Hyperglycaemia
- Focus Therapeutic Use
- 16 Apr 2018 Status changed from active, no longer recruiting to completed.
- 19 May 2015 Status changed from recruiting to active, no longer recruiting as per ClinicalTrials.gov record.
- 06 May 2013 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov record.